| Female Reproductive System Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived106 of 106show fewer |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 71 trials (22 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 55 trials (19 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 41 trials (8 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 39 trials (17 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 18 trials (13 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 16 trials (12 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 15 trials (6 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 13 trials (7 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avutometinib And Defactinib 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Megestrolsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirvetuximab Soravtansineadc 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-VEGF Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camizestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eprenetapoptsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hyperthermic Intraperitoneal Chemotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imlunestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onalespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uprosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |